Sign In
Buy IDXG
$1.75
-0.0100 (-0.568%)
At Close: Jun 03, 2026
Interpace Diagnostics Group (IDXG) Receives a Buy from Oppenheimer - Markets
03:51am, Friday, 26'th Jun 2020
Oppenheimer analyst Kevin DeGeeter maintained a Buy rating on Interpace Diagnostics Group (IDXG – Research Report) yesterday and set a
Edited Transcript of IDXG earnings conference call or presentation 25-Jun-20 8:30pm GMT
10:06pm, Thursday, 25'th Jun 2020
Q1 2020 Interpace Biosciences Inc Earnings Call
Interpace Biosciences Announces First Quarter 2020 Financial and Business Results
08:59pm, Thursday, 25'th Jun 2020
First Quarter Net Revenue Improved Over 53% to $9.2 Million Launching COVID-19 Serology Testing Continues to Integrate Service Offerings and Streamline Costs Conference Call.
Interpace Biosciences, Inc. (IDXG) CEO Jack Stover on Q1 2020 Results - Earnings Call Transcript
07:57pm, Thursday, 25'th Jun 2020
Interpace Biosciences, Inc. (NASDAQ:IDXG) Q1 2020 Earnings Conference Call June 25, 2020 04:30 PM ET Company Participants Jack Stover - President and CEO Fred K
Maxim Group Gives a Buy Rating to Titan Pharmaceuticals (TTNP) - Markets
05:24pm, Thursday, 25'th Jun 2020
Maxim Group analyst Jason McCarthy assigned a Buy rating to Titan Pharmaceuticals (TTNP – Research Report) today and set a
Soligenix (SNGX) Receives a Buy from Maxim Group - Markets
05:16pm, Thursday, 25'th Jun 2020
In a report released today, Jason McCarthy from Maxim Group assigned a Buy rating to Soligenix (SNGX – Research Report),
Cancer Genetics Reports First Quarter 2020 Financial Results and Provides Strategic Business Updates | MarketScreener
09:31pm, Wednesday, 24'th Jun 2020Interpace Biosciences to Host Conference Call and Webcast to Discuss First Quarter, 2020 Financial Results on Thursday June 25, 2020
08:20pm, Wednesday, 24'th Jun 2020
Interpace Biosciences (IDXG) announced today that it will report its first quarter, 2020 financial results on Thursday, June 25, 2020 at 4:30 p.m. ET. Interpace will host a conference call and webcas
Personalis (PSNL) Gets a Buy Rating from Oppenheimer - Markets
04:19pm, Wednesday, 24'th Jun 2020
Oppenheimer analyst Kevin DeGeeter assigned a Buy rating to Personalis (PSNL – Research Report) today and set a price target
Comparing Interpace Diagnostics Group (NASDAQ:IDXG) & Utah Medical Products (NASDAQ:UTMD)
01:36am, Wednesday, 24'th Jun 2020
Utah Medical Products (NASDAQ:UTMD) and Interpace Diagnostics Group (NASDAQ:IDXG) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the
Maxim Group Thinks BioNano Genomics' Stock is Going to Recover - Markets
01:09pm, Tuesday, 23'rd Jun 2020
In a report released today, Jason McCarthy from Maxim Group maintained a Buy rating on BioNano Genomics (BNGO – Research
Celcuity (CELC) Gets a Buy Rating from H.C. Wainwright - Markets
10:25am, Tuesday, 23'rd Jun 2020
In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on Celcuity (CELC – Research Report),
Oppenheimer Maintains Their Buy Rating on Vascular Biogenics (VBLT) - Markets
12:42am, Tuesday, 23'rd Jun 2020
Oppenheimer analyst Kevin DeGeeter maintained a Buy rating on Vascular Biogenics (VBLT – Research Report) yesterday and set a price
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Fate Therapeutics (FATE – Research
Maxim Group Assigns a Buy Rating on Heat Biologics (HTBX) - Markets
05:31pm, Friday, 19'th Jun 2020
Maxim Group analyst Jason McCarthy assigned a Buy rating to Heat Biologics (HTBX – Research Report) today and set a
